Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells

被引：0
|
作者：
Hannah Schmucker
Walker M. Blanding
Julia M. Mook
Jessica F. Wade
Jang Pyo Park
Kerri Kwist
Hiral Shah
Brian W. Booth
机构：
[1] Clemson University,Department of Biological Sciences
[2] Clemson University,Department of Microbiology
[3] Clemson University,Institute for Biological Interfaces of Engineering
[4] Clemson University,Department of Bioengineering, Institute for Biological Interfaces of Engineering
来源：
Cellular Oncology | 2018年 / 41卷
关键词：
Amphiregulin; Breast cancer; erbB2; HER2; Migration; Transfection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：159 / 168
页数：9
相关论文
共 50 条
  • [1] Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells
    Schmucker, Hannah
    Blanding, Walker M.
    Mook, Julia M.
    Wade, Jessica F.
    Park, Jang Pyo
    Kwist, Kerri
    Shah, Hiral
    Booth, Brian W.
    CELLULAR ONCOLOGY, 2018, 41 (02) : 159 - 168
  • [2] Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration
    Yeh, Elizabeth S.
    Williams, Christina J.
    Williams, Carly Bess
    Bonilla, Ingrid V.
    Klauber-DeMore, Nancy
    Phillips, Stephanie L.
    ONCOTARGET, 2017, 8 (65) : 109358 - 109369
  • [3] Lapatinib inhibits doxorubicin induced migration of HER2-positive breast cancer cells
    Chintalaramulu, Naveen
    Vadivelu, Raja
    Nam-Trung Nguyen
    Cock, Ian Edwin
    INFLAMMOPHARMACOLOGY, 2020, 28 (05) : 1375 - 1386
  • [4] Lapatinib inhibits doxorubicin induced migration of HER2-positive breast cancer cells
    Naveen Chintalaramulu
    Raja Vadivelu
    Nam-Trung Nguyen
    Ian Edwin Cock
    Inflammopharmacology, 2020, 28 : 1375 - 1386
  • [5] Dishevelled 2 regulates cancer cell proliferation and T cell mediated immunity in HER2-positive breast cancer
    Fahmida Rasha
    Geetha Priya Boligala
    Mingxiao V. Yang
    Dalia Martinez-Marin
    Isabel Castro-Piedras
    Kathryn Furr
    Annie Snitman
    Sonia Y. Khan
    Luis Brandi
    Maribel Castro
    Hafiz Khan
    Nusrat Jahan
    Sharilyn Almodovar
    Michael W. Melkus
    Kevin Pruitt
    Rakhshanda Layeequr Rahman
    BMC Cancer, 23
  • [6] Dishevelled 2 regulates cancer cell proliferation and T cell mediated immunity in HER2-positive breast cancer
    Rasha, Fahmida
    Boligala, Geetha Priya
    Yang, Mingxiao V.
    Martinez-Marin, Dalia
    Castro-Piedras, Isabel
    Furr, Kathryn
    Snitman, Annie
    Khan, Sonia Y.
    Brandi, Luis
    Castro, Maribel
    Khan, Hafiz
    Jahan, Nusrat
    Almodovar, Sharilyn
    Melkus, Michael W.
    Pruitt, Kevin
    Rahman, Rakhshanda Layeequr
    BMC CANCER, 2023, 23 (01)
  • [7] HER2-positive breast cancer
    Loibl, Sibylle
    Gianni, Luca
    LANCET, 2017, 389 (10087): : 2415 - 2429
  • [8] MEK Inhibition in HER2-Positive Breast Cancer Cells
    Courtney, Alona
    Welch, Hazel
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 18 - 19
  • [9] Metabolomic Analysis of HER2-positive Breast Cancer Cells
    Bush, Jason A.
    Sahni, Malika K.
    Ravindran, Resmi K.
    Khan, Imran H.
    Krishnan, Viswanathan V.
    FASEB JOURNAL, 2018, 32 (01):
  • [10] HER2-Positive Circulating Tumor Cells in Breast Cancer
    Ignatiadis, Michail
    Rothe, Francoise
    Chaboteaux, Carole
    Durbecq, Virginie
    Rouas, Ghizlane
    Criscitiello, Carmen
    Metallo, Jessica
    Kheddoumi, Naima
    Singhal, Sandeep K.
    Michiels, Stefan
    Veys, Isabelle
    Rossari, Jose
    Larsimont, Denis
    Carly, Birgit
    Pestrin, Marta
    Bessi, Silvia
    Buxant, Frederic
    Liebens, Fabienne
    Piccart, Martine
    Sotiriou, Christos
    PLOS ONE, 2011, 6 (01):
12345